Scientific Sessions 2024  /  Featured Science: Incretin Modulation: Is a New Standard of Care Emerging?  /  Discussant: SUMMIT CMR
Logo

American Heart Association

  113
  0

Final ID:

Discussant: SUMMIT CMR

  • Kramer, Chris  ( CCHMC , Cincinnati , Ohio , United States )
  • Rider, Oliver  ( CCHMC , Cincinnati , Ohio , United States )
  • Wilcox, Jane  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
    • Author Disclosures:
    Chris Kramer: No Answer | Oliver Rider: DO NOT have relevant financial relationships | Jane Wilcox: DO have relevant financial relationships ; Advisor:Abiomed:Active (exists now) ; Consultant:Astra Zeneca:Past (completed) ; Speaker:Boehringer Ingelheim:Active (exists now) ; Consultant:Abbott:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Incretin Modulation: Is a New Standard of Care Emerging?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Discussant: SUMMIT

Lewis Eldrin

Effects of Tirzepatide on the Clinical and Symptom Burden of Patients with Heart Failure and a Preserved Ejection Fraction, Results from the SUMMIT Trial

Zile Michael

More abstracts from these authors:
PREVENT the Perfect Storm: Managing Metabolic Syndrome

Harrington Josephine, Dixon Dave, Wilcox Jane

Lost to Follow Up: A Rare Case of Malonyl-CoA Decarboxylase Deficiency Induced Cardiomyopathy in an Adult Spanish Speaking Hispanic Male

Iniguez Reniell, Quaggin-smith Jessica, Hale Sarah, Wilcox Jane

You have to be authorized to contact abstract author. Please, Login
Not Available